Methyl (6-(3-cyclopropyl-5-methyl-1H-pyrazol-4-yl)-1H-indazol-4-yl)carbamate

Catalog No. :
ACVJWK962
CAS No. :
2146177-09-3
Molecular Formula :
C16H17N5O2
Molecular Weight :
311.35

IUPAC Name:methyl (6-(3-cyclopropyl-5-methyl-1H-pyrazol-4-yl)-1H-indazol-4-yl)carbamate

Methyl (6-(3-cyclopropyl-5-methyl-1H-pyrazol-4-yl)-1H-indazol-4-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$171.00Login to see priceInquiryInquiry
5mg98%$376.00Login to see priceInquiryInquiry
10mg98%$601.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl (6-(3-cyclopropyl-5-methyl-1H-pyrazol-4-yl)-1H-indazol-4-yl)carbamate
IUPAC Namemethyl (6-(3-cyclopropyl-5-methyl-1H-pyrazol-4-yl)-1H-indazol-4-yl)carbamate
Molecular FormulaC16H17N5O2
Molecular Weight311.35
SMILESO=C(NC1=CC(C2=C(NN=C2C3CC3)C)=CC4=C1C=NN4)OC
InChI KeyQTYLFQMDDFBRTJ-UHFFFAOYSA-N
SynonymDS28120313;Methyl Ester N-[6-(3-Cyclopropyl-5-methyl-1H-pyrazol-4-yl)-1H-indazol-4-yl]carbamic Acid;DS-28120313,DS28120313;Carbamic acid, N-[6-(3-cyclopropyl-5-methyl-1H-pyrazol-4-yl)-1H-indazol-4-yl]-, methyl ester
CAS No.2146177-09-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACVJWK962 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVJWK962 route product structure diagram
    ACVJWK9622146177-09-3
Inquiry

2. ACVJWK962 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVJWK962 route product structure diagram
    ACVJWK9622146177-09-3
Inquiry

Comments (0)